1. Home
  2. ADV vs BBOT Comparison

ADV vs BBOT Comparison

Compare ADV & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$28.32

Market Cap

523.2M

ML Signal

HOLD

Logo BridgeBio Oncology Therapeutics Inc.

BBOT

BridgeBio Oncology Therapeutics Inc.

HOLD

Current Price

$2.68

Market Cap

442.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
BBOT
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
523.2M
442.6M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
ADV
BBOT
Price
$28.32
$2.68
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
★ $42.00
$24.55
AVG Volume (30 Days)
47.5K
★ 520.6K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.93
EPS
★ N/A
N/A
Revenue
★ $3,542,642,000.00
N/A
Revenue This Year
$1.41
N/A
Revenue Next Year
$1.27
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.49
$2.71
52 Week High
$47.45
$14.87

Technical Indicators

Market Signals
Indicator
ADV
BBOT
Relative Strength Index (RSI) 42.42 14.74
Support Level $25.73 N/A
Resistance Level $34.96 $9.36
Average True Range (ATR) 1.65 0.23
MACD 0.01 0.08
Stochastic Oscillator 36.32 0.37

Price Performance

Historical Comparison
ADV
BBOT

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

About BBOT BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Share on Social Networks: